Adore Pharmaceuticals Pvt Ltd

Adore Pharmaceuticals Pvt Ltd - pharma in Vasai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1985PTC035071 Incorporated 15 January 1985 ROC Mumbai HQ Vasai, Maharashtra, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹14.54 Cr
▲ 3% YoY
Net profit · FY 2024
₹24.84 Lakh
Net margin 1.7%
EBITDA · FY 2024
₹1.29 Cr
EBITDA margin 8.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹48 Lakh
Satisfied ₹26.9 Lakh
Company age
41 yrs
Est. 1985
Employees · EPFO
45
Provident fund records

About Adore Pharmaceuticals Pvt Ltd

Data last updated:

Adore Pharmaceuticals Pvt Ltd is a private limited company based in Vasai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 January 1985 and has been in existence for over 41 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1985PTC035071. Its GSTIN is 27AAACA8438M1ZB (Maharashtra).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Meeta Samir Sheth (Managing Director) and Sachin Navinchandra Doshi.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 5 – 6 Khokhani Industrial Complex Number. 2 Near Sai Temple Sativali Vasai (E), Maharashtra, India – 401208.

As per the financials filed for FY 2024, the company reported a revenue of ₹14.54 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹24.84 Lakh (net margin 1.7%) and EBITDA of ₹1.29 Cr (EBITDA margin 8.9%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 4% over five years.

The company has about 45 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹48 Lakh and satisfied charges of ₹26.9 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.

Adore Pharmaceuticals Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0056755). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website adorepharma.com.

Company details

CIN U24230MH1985PTC035071
Registration Number 035071
Incorporation Date 15 January 1985
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-17-0056755

Recognitions & Rankings of Adore Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-17-0056755

Contact details

Adore Pharmaceuticals Pvt Ltd's registered office is in Vasai, Maharashtra. Its website is adorepharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    5 – 6 Khokhani Industrial Complex Number. 2 Near Sai Temple Sativali Vasai (E), Maharashtra, India – 401208
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Adore Pharmaceuticals Pvt Ltd, buy the company report.

Comprehensive company report
Adore Pharmaceuticals Pvt Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Adore Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Adore Pharmaceuticals Pvt Ltd, buy the company report.

Financials of Adore Pharmaceuticals Pvt Ltd

FY 2024 filings available

Adore Pharmaceuticals Pvt Ltd reported revenue of ₹14.54 Cr (up 3% YoY) for FY 2024.

Revenue · FY 2024
₹14.54 Cr ▲ 3%
Net profit · FY 2024
₹24.84 Lakh margin 1.7%
EBITDA · FY 2024
₹1.29 Cr margin 8.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 23%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 10%
3 years · compounded
▼ 4%
5 years · compounded
▼ 12%

Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 3% growth in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.29 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹24.84 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin8.9%
Net Profit Margin1.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Adore Pharmaceuticals Pvt Ltd, buy the company report.

Board of directors of Adore Pharmaceuticals Pvt Ltd

Adore Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sachin Navinchandra DoshiDirector15 Jan 198541 Years 9 MonthsCurrent
Meeta Samir ShethManaging Director01 Feb 20215 Years 8 MonthsCurrent
Samir Anil ShethDirector15 Jan 198541 Years 9 MonthsCurrent

Peer comparison

Adore Pharmaceuticals Pvt Ltd is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Life Medicare and Biotech Private Limited₹14.62 Cr (FY 2025)328658.0%New Delhi, Delhi, India
Aditi Pharmaceuticals Pvt Ltd₹14.54 Cr (FY 2025)-8.0%Solapur, Maharashtra, India
Adore Pharmaceuticals Pvt Ltdthis company₹14.54 Cr (FY 2024)₹24.84 Lakh1.7%3.0%45Vasai, Maharashtra, India
Lactonova Nutripharm Private Limited₹14.52 Cr (FY 2025)28.0%Hyderabad, Telangana, India

To see the full peer comparison of Adore Pharmaceuticals Pvt Ltd, buy the company report.

Auditor

Adore Pharmaceuticals Pvt Ltd is audited by Paresh Vora & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Paresh Vora & AssociatesFY 2023118090W

Shareholding

The shareholding of Adore Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Adore Pharmaceuticals Pvt Ltd, buy the company report.

Charges & borrowings

Open charges
₹48 Lakh
Satisfied charges
₹26.9 Lakh
Breakdown by lending institutions
State Bank of India₹0.48 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Nov 199290358614State Bank of India₹48 LakhOpen
08 May 198790358126State Bank of India₹26.9 LakhSatisfied

To see the full charge records of Adore Pharmaceuticals Pvt Ltd, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

Adore Pharmaceuticals Pvt Ltd has 1 MSME Form 1 return on record for the period ending Sep 2019, listing 4 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (4 of 4)

SupplierAmount dueDue sinceReported on
H K Printers Private Limited
Gorang International
Mak Ampoules Pvt Ltd
Mak Polyplast Private Limited

To see the full MSME payment records of Adore Pharmaceuticals Pvt Ltd, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Adore Pharmaceuticals Pvt Ltd has a workforce of 45 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.

Employee count
45
Active EPFO establishments
1
Employee growth
-8.16%

GST

Adore Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACA8438M1ZBMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Adore Pharmaceuticals Pvt Ltd, buy the company report.

Recent activity

Adore Pharmaceuticals Pvt Ltd has 5 board changes on record since 1985: 3 appointments and 2 cessations. The latest: Meeta Samir Sheth ceased to be Additional Director on 30 Nov 2021.

AGM
Adore Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Adore Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Meeta Samir Sheth ceased to be Additional Director.
Appointed
Meeta Samir Sheth was appointed as Managing Director.
Ceased
Navin Bachubhai Doshi ceased to be Director.
Charges
A charge registered on 08 May 1987 via Charge ID 90358126 with State Bank Of India was fully satisfied on 08 May 2013.
Charges
A charge with State Bank Of India amounted to Rs. 48.00 Lakh with Charge ID 90358614 was registered on 11 Nov 1992.
Charges
A charge with State Bank Of India of Rs. 26.90 Lakh registered on 08 May 1987 with Charge ID 90358126 was modified on 27 Mar 1989.
Charges
A charge with State Bank Of India amounted to Rs. 26.90 Lakh with Charge ID 90358126 was registered on 08 May 1987.
Appointed
Sachin Navinchandra Doshi was appointed as Director.
Appointed
Samir Anil Sheth was appointed as Director.
Incorporation
15 Jan 1985
Adore Pharmaceuticals Pvt Ltd was registered on 15 Jan 1985 with Roc Mumbai & aged 41 years 9 months as per MCA records.

Frequently asked questions

Adore Pharmaceuticals is an active private limited company based in Vasai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 January 1985 (41+ years old) and is registered under CIN U24230MH1985PTC035071.

Adore Pharmaceuticals has 3 current directors:

The latest financial statements of Adore Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Adore Pharmaceuticals is 27AAACA8438M1ZB, registered in Maharashtra.

The CIN (Corporate Identification Number) of Adore Pharmaceuticals is U24230MH1985PTC035071. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Adore Pharmaceuticals has 2 court cases on record: 2 filed against it. 1 is pending. Most are in the district courts.

Adore Pharmaceuticals was incorporated on 15 January 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Adore Pharmaceuticals by revenue are Life Medicare and Biotech Private Limited, Aditi Pharmaceuticals Pvt Ltd, Lactonova Nutripharm Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Meeta Samir Sheth ceased to be Additional Director on 30 Nov 2021. Meeta Samir Sheth was appointed as Managing Director on 01 Feb 2021. Navin Bachubhai Doshi ceased to be Director on 01 Feb 2021. Adore Pharmaceuticals has 5 board changes on record in total.

Yes, Adore Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-17-0056755).

Adore Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Sep 2019, listing 4 overdue payments to 4 micro and small suppliers. The latest return was filed on 10 Dec 2019.

Adore Pharmaceuticals can be reached through the website adorepharma.com. Its registered office is in Vasai, Maharashtra, India.